Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-03-29 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document text is titled "Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram" (Transactions related to Novozymes' share buyback program). It details the number of shares bought back, the transaction value, and specific dates (March 21 to March 25, 2016) under a stated buyback program, referencing a previous company announcement (selskabsmeddelelse nr. 2, 2016) and regulatory framework (Safe Harbour Regulation). This content directly relates to the company repurchasing or dealing in its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document length is short (2944 chars), but it is a detailed report of transactions, not an announcement *about* a report, thus POS is preferred over RPA/RNS.
2016-03-29 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document announces that Novozymes has repurchased 1,299,000 of its own shares under its announced share buyback program, detailing transaction volumes and dates. This is a classic share repurchase report rather than a full financial report or other type of filing.
2016-03-29 Danish
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement detailing the company's ongoing stock buyback program, specifically listing the number of shares purchased, average prices, and transaction values over a specific period. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2016-03-29 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text is very short (265 characters) and describes a transaction where Novozymes bought back a specific number of shares under a previously announced share repurchase program. The key phrase is 'købt i alt 1.203.000 aktier' (bought a total of 1,203,000 shares) related to a 'aktietilbagekøbsprogram' (share repurchase program). This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this might be a summary, but the core content is the transaction itself, making POS a stronger fit than RPA or RNS, as it details the action taken under the program, not just the announcement of a report.
2016-03-21 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program,' reporting the number of shares purchased, the average price, and the total transaction value over several days (March 14 to March 18, 2016). This directly corresponds to the definition of a company reporting on the repurchase or sale of its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K) as it focuses solely on share transactions.
2016-03-21 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 85% confidence The text reports that Novozymes has purchased its own shares under a stock buyback program, specifying the number of shares and transaction value. This matches the description for Transaction in Own Shares (code POS). It is not merely an announcement of a report or a dividend notice, but an actual share repurchase announcement.
2016-03-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.